Navidea Biopharmaceuticals (NAVB) News Today $0.0010 0.00 (0.00%) (As of 01:57 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Navidea Biopharmaceuticals (NYSE:NAVB) Earns Sell Rating from Analysts at StockNews.comNovember 15, 2024 | americanbankingnews.comNavidea Biopharmaceuticals (NYSE:NAVB) Now Covered by StockNews.comNovember 11, 2024 | americanbankingnews.comNavidea Biopharmaceutical (OTC:NAVB) Stock Quotes, Forecast and News SummaryOctober 28, 2024 | benzinga.comNavidea Biopharmaceuticals, Inc. Announces Results of Exploratory Analysis Completed on July 2, 2024July 3, 2024 | businesswire.comNavidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024June 20, 2024 | businesswire.comSK Biopharmaceuticals Co. Ltd.May 25, 2024 | wsj.comDay One Biopharmaceuticals, Inc. Common Stock (DAWN)May 3, 2024 | nasdaq.comNavidea Biopharmaceutical Stock (OTC:NAVB), Short Interest ReportFebruary 23, 2024 | benzinga.comNavidea Biopharmaceutical Stock (OTC:NAVB) Dividends: History, Yield and DatesFebruary 22, 2024 | benzinga.comNavidea Biopharmaceutical Stock (OTC:NAVB) Insider TradesFebruary 22, 2024 | benzinga.comCentral Ohio public company voluntarily deregisters stockJanuary 29, 2024 | bizjournals.comNavidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting ObligationsJanuary 26, 2024 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting ObligationsJanuary 26, 2024 | finance.yahoo.comSuzhou Zelgen Biopharmaceuticals Co Ltd (688266)January 11, 2024 | investing.comNavidea settles litigation with Capital Royalty, stock rallies 30%December 1, 2023 | msn.comNavidea Biopharmaceuticals, CRG Settle All Ongoing LitigationDecember 1, 2023 | markets.businessinsider.comNavidea Biopharmaceuticals Inc NAVBNovember 1, 2023 | morningstar.comNavidea Biopharmaceuticals faces delisting from NYSE American, plans to move to OTC marketsOctober 26, 2023 | investing.comNYSE American halts trading on Navidea stock after delisting recommendedOctober 6, 2023 | bizjournals.comNavidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common StockOctober 5, 2023 | finance.yahoo.comNYSE American to Suspend Trading in Navidea Biopharmaceuticals, Inc. (NAVB)October 5, 2023 | tmcnet.comNavidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing PanelAugust 10, 2023 | finance.yahoo.comNYSE American starts to delist Navidea stock, company to appealAugust 1, 2023 | finance.yahoo.comWhy Navidea Biopharmaceuticals Shares Are NosedivingJuly 31, 2023 | benzinga.comNavidea Biopharmaceuticals, Inc. Presses Ahead, Embraces OpportunitiesJuly 31, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American DeterminationJuly 28, 2023 | finance.yahoo.comNYSE American to Commence Delisting Proceedings Against Navidea Biopharmaceuticals, Inc. (NAVB)July 28, 2023 | businesswire.comNavidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as Chief Financial OfficerJuly 28, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps DownJuly 13, 2023 | finance.yahoo.comDublin biotech proposes reverse stock split, stock-for-debt swapJuly 6, 2023 | bizjournals.comNavidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain AssetsJune 30, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Announces Distribution of Series K Preferred Stock to Holders of its Common StockJune 16, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health in Lieu of Contingent Milestone PaymentJune 16, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Reports First Quarter 2023 Financial Results and Provides Business UpdateJune 7, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Receives NYSE American NoticeJune 2, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Investors Purchase $1.1 Million in Preferred Shares at MarketMay 22, 2023 | finance.yahoo.comNavidea Biopharma (NAVB) Earnings Dates & ReportsMay 15, 2023 | investing.comNavidea promotes Michael Sherman Blue to CMO postMay 11, 2023 | msn.comNavidea Biopharmaceuticals, Inc. Drives Strategy Forward, Shifts Approach for CommunicationsMay 8, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of CreditApril 27, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Enters Asset Purchase Agreement with Meilleur Technologies, Inc. for Rights to NAV4694April 13, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. Hires G2G Ventures as Executive Consultants; Chief Medical Officer Steps DownMarch 30, 2023 | businesswire.comNavidea Biopharmaceuticals, Inc. (AMEX:NAVB) Q4 2022 Earnings Call TranscriptMarch 24, 2023 | finance.yahoo.comQ4 2022 Navidea Biopharmaceuticals Inc Earnings CallMarch 22, 2023 | finance.yahoo.comNavidea Biopharmaceuticals Reports Fourth Quarter 2022 Financial ResultsMarch 21, 2023 | finance.yahoo.comNavidea Biopharmaceuticals to Host Fourth Quarter 2022 Earnings Conference Call and Business UpdateMarch 15, 2023 | finance.yahoo.comNAVB.PH - | Stock Price & Latest News | ReutersJanuary 24, 2023 | reuters.comNavidea stock soars ~25% on upcoming US patent linked to cancer drug pipelineJanuary 3, 2023 | msn.comNavidea Biopharmaceuticals Announces the Notice of Allowance for U.S. Patent Application for Key Component of the Company’s Cancer Immunotherapy PipelineJanuary 3, 2023 | finance.yahoo.comNavidea Biopharmaceuticals, Inc. (AMEX:NAVB) Q3 2022 Earnings Call TranscriptDecember 28, 2022 | finance.yahoo.com Get Navidea Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NAVB and its competitors with MarketBeat's FREE daily newsletter. Email Address When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again. Use this link to see Nvidia Unchained right away! NAVB Media Mentions By Week NAVB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NAVB News Sentiment▼0.000.47▲Average Medical News Sentiment NAVB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NAVB Articles This Week▼10▲NAVB Articles Average Week Get Navidea Biopharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NAVB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies NexImmune News Today TC Biopharm News Today Smart for Life News Today Seelos Therapeutics News Today TRACON Pharmaceuticals News Today Vaxxinity News Today Ampio Pharmaceuticals News Today Statera Biopharma News Today eFFECTOR Therapeutics News Today Alvotech News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:NAVB) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Navidea Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Navidea Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NAVB Stock Alerts